NCT06334731View on ClinicalTrials.gov

Antimicrobial Resistance During the SARS-CoV-2 (COVID-19) Pandemic

CompletedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

July 6, 2021

Primary Completion Date

July 14, 2025

Study Completion Date

July 14, 2025

Conditions
COVID-19
Trial Locations (1)

75203

Methodist Dallas Medical Center, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER